Surgical Innovations Group (SUN) Competitors

GBX 0.50
0.00 (0.00%)
(As of 05/10/2024 ET)

SUN vs. MHC, DEMG, RUA, POLX, IHC, BELL, VAL, BSFA, GDR, and IXI

Should you be buying Surgical Innovations Group stock or one of its competitors? The main competitors of Surgical Innovations Group include MyHealthChecked (MHC), Deltex Medical Group (DEMG), RUA Life Sciences (RUA), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Belluscura (BELL), ValiRx (VAL), BSF Enterprise (BSFA), genedrive (GDR), and IXICO (IXI). These companies are all part of the "medical" sector.

Surgical Innovations Group vs.

MyHealthChecked (LON:MHC) and Surgical Innovations Group (LON:SUN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends, community ranking and profitability.

Surgical Innovations Group received 121 more outperform votes than MyHealthChecked when rated by MarketBeat users.

CompanyUnderperformOutperform
MyHealthCheckedN/AN/A
Surgical Innovations GroupOutperform Votes
121
68.36%
Underperform Votes
56
31.64%

MyHealthChecked has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, Surgical Innovations Group has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500.

MyHealthChecked has higher revenue and earnings than Surgical Innovations Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MyHealthChecked£14.95M0.35£1.52MN/AN/A
Surgical Innovations Group£12.01M0.39N/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MyHealthChecked
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Surgical Innovations Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

3.1% of MyHealthChecked shares are held by institutional investors. Comparatively, 40.2% of Surgical Innovations Group shares are held by institutional investors. 38.6% of MyHealthChecked shares are held by company insiders. Comparatively, 48.2% of Surgical Innovations Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

MyHealthChecked has a net margin of 1.26% compared to MyHealthChecked's net margin of -4.24%. Surgical Innovations Group's return on equity of 2.22% beat MyHealthChecked's return on equity.

Company Net Margins Return on Equity Return on Assets
MyHealthChecked1.26% 2.22% 6.38%
Surgical Innovations Group -4.24%-4.75%-2.49%

In the previous week, Surgical Innovations Group had 1 more articles in the media than MyHealthChecked. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for MyHealthChecked. MyHealthChecked's average media sentiment score of 0.35 beat Surgical Innovations Group's score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the news media.

Company Overall Sentiment
MyHealthChecked Neutral
Surgical Innovations Group Neutral

Summary

MyHealthChecked and Surgical Innovations Group tied by winning 6 of the 12 factors compared between the two stocks.

Get Surgical Innovations Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SUN and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SUN vs. The Competition

MetricSurgical Innovations GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£4.66M£2.15B£5.09B£1.70B
Dividend Yield2.63%2.55%37.69%7.64%
P/E Ratio-21.11240.10172.711,949.67
Price / Sales0.39257.472,422.76412,360.05
Price / Cash5.0316.3048.1035.02
Price / Book0.503.575.322.72
Net IncomeN/A£61.04M£106.30M£180.67M
7 Day PerformanceN/A1.58%-0.89%1.34%
1 Month Performance11.11%-0.62%-1.39%3.07%
1 Year Performance-73.12%37.89%4.72%10.46%

Surgical Innovations Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MHC
MyHealthChecked
0 of 5 stars
GBX 10
flat
N/A+629.9%£5.20M£14.95M316.6721
DEMG
Deltex Medical Group
0 of 5 stars
GBX 0.13
flat
N/A-92.0%£2.38M£1.78M-5.7537Gap Up
RUA
RUA Life Sciences
0 of 5 stars
GBX 11.50
+1.1%
N/A-71.3%£7.14M£1.87M-143.7548
POLX
Polarean Imaging
0 of 5 stars
GBX 3.70
flat
N/A-85.3%£8.00M£1.03M-74.0028News Coverage
Gap Down
IHC
Inspiration Healthcare Group
0 of 5 stars
GBX 16.75
flat
N/A-63.8%£11.43M£41.08M-1,675.00210Positive News
BELL
Belluscura
0 of 5 stars
GBX 8
+3.2%
N/A-72.3%£13.15M£1.20M-133.3324Gap Up
VAL
ValiRx
0 of 5 stars
GBX 3.30
+1.5%
N/A-69.5%£4.37MN/A-110.008
BSFA
BSF Enterprise
0 of 5 stars
GBX 5
flat
N/A-66.7%£5.17MN/A-250.0012
GDR
genedrive
0 of 5 stars
GBX 3.88
-11.4%
N/A-89.0%£5.37M£49,000.00-77.5043News Coverage
IXI
IXICO
0 of 5 stars
GBX 8.13
flat
N/A-60.8%£3.93M£6.67M-406.2589News Coverage

Related Companies and Tools

This page (LON:SUN) was last updated on 5/12/2024 by MarketBeat.com Staff

From Our Partners